Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2025/07/091590
CTRI/2025/07/091590
Recruiting
Not Applicable

A Comparative Clinical Study To Evaluate The Efficacy Of Kustadi Taila And Lakshadi Taila Nasya In Vataja Pratishyaya W.S.R Allergic Rhinitis

SHRI VIJAY MAHANTESH AYURVEDIC MEDICAL COLLEGE ILKAL BAGALKOT KARNATAKA1 site in 1 country40 target enrollmentStarted: August 29, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
SHRI VIJAY MAHANTESH AYURVEDIC MEDICAL COLLEGE ILKAL BAGALKOT KARNATAKA
Enrollment
40
Locations
1
Primary Endpoint
Reduced symptoms of Running nose Nasal obstruction Sneezing
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

The Prevalence Of Allergic Rhinitis Is Approximately 20% Of Population In India

Treatment Nasya karma for 7 days is undertaken and  First Follow up on 15th day And 2nd Follow up on 22nd day

Thus Ensuring its Beneficiency an Attempt is Made Through Comparative Study of Kustadi and Lakshadi Taila in Vataja Pratishyaya Aiming to Improve their Quality of life Hence the study taken and entitled as

A Comparative Clinical Study To Evaluate The Efficacy Of Kustadi Taila Nasya and Lakshadi Taila Nasya In Vataja Pratishyaya W S R Allergic Rhinitis

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Patients Who Are Fit For Nasya Karma Will Be Selected.
  • •2.Patients Between The Age Groups Of 18 to 60 Years of Either Sex 3.The Cases of Vataja Pratisyaya Presenting With Signs And Symptoms As Per Classics are Included.

Exclusion Criteria

  • •1.Patient Who Are Contraindicated For Nasya Karma Are Excluded.
  • •2.Patient With Nasal Polyp, DNS, Sinusities, Tumors Are Excluded.
  • •3.Patient with other Systemic Disorders.
  • •4.Suffering from Any Infectious Disease of Nose And Endocranial Disorders Are Excluded.

Outcomes

Primary Outcomes

Reduced symptoms of Running nose Nasal obstruction Sneezing

Time Frame: 22 Days

Secondary Outcomes

  • Reduced All symptoms of Running nose Nasal obstruction and Sneezing(22 days)

Investigators

Sponsor
SHRI VIJAY MAHANTESH AYURVEDIC MEDICAL COLLEGE ILKAL BAGALKOT KARNATAKA
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Priyanka R Sudi

Shri Vijay Mahantesh Ayurvedic medical college Ilkal

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 2/3
To assess the effect and safety of fluticasone nasal spray in allergic rhinitis
CTRI/2025/04/083804NA80
Not yet recruiting
Not Applicable
To Study the ffectiveness of Individualized Homoeopathic Medicine in Fifty Millesimal Potency in the Management of Allergic Rhinitis Among Adults
CTRI/2025/10/096028Dr Tejal Kailas Tagwale36
Not yet recruiting
Phase 2
Research on the potential benefits of homeopathic remedies for adults (18–40 years old) suffering from allergic rhinitis to lessen symptoms and the need for conventional allopathic medications.
CTRI/2025/09/095044Dr Surendra Kumar136
Not yet recruiting
Phase 2/3
study of an ayurvedic preparation pippalyadi vati in the management of disease Vataj pratishyay which is correlated with disease acute rhinitis in modern science
CTRI/2025/04/084295Dr Poonam Laxman Powar84
Not yet recruiting
Not Applicable
Study to Assess the Role of Individualized Homoeopathic Medicine in Cases of Allergic Rhinitis Considering Kents Twelve Observations at Follow Ups
CTRI/2025/08/092146Swasthya Kalyan Homoeopathic Medical College and Research Centre31